Prognostic Value of Non-Contrast CT Markers and Spot Sign for Outcome Prediction in Patients with Intracerebral Hemorrhage under Oral Anticoagulation.

computed tomography intracerebral hemorrhage outcome prediction

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
10 Apr 2020
Historique:
received: 17 03 2020
revised: 31 03 2020
accepted: 07 04 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 16 4 2020
Statut: epublish

Résumé

In patients with spontaneous intracerebral hemorrhage (ICH), several non-contrast computed tomography (NCCT) markers and the spot sign (SS) in computed tomography (CT) angiography (CTA) have been established for the prediction of hematoma growth and neurological outcome. However, the prognostic value of these markers in patients under oral anticoagulation (ORAC) is unclear. We hypothesized that outcome prediction by these imaging markers may be significantly different between patients with and without ORAC. Therefore, we aimed to investigate the predictive value of NCCT markers and SS in patients with ICH under ORAC. This is a retrospective study of the database for patients with ICH at a German tertiary stroke center. Inclusion criteria were (1) patients with ICH, (2) oral anticoagulation within the therapeutic range, and (3) NCCT and CTA performed on admission within 6 h after onset of symptoms. We defined a binary outcome: modified Rankin Scale (mRS) ≤ 3 = good outcome versus mRS > 3 = poor outcome at discharge. The predictive value of each sign was assessed in uni- and multivariable logistic regression models. Of 129 patients with ICH under ORAC, 76 (58.9%) presented with hypodensities within the hematoma in admission NCCT, 64 (52.7%) presented with an irregular shape of the hematoma, 60 (46.5%) presented with a swirl sign, 49 (38.0%) presented with a black hole sign, and 46 (35.7%) presented with a heterogeneous density of the hematoma. Moreover, 44 (34.1%) patients had a satellite sign, in 20 (15.5%) patients, an island sign was detected, 18 (14.0%) patients were blend-sign positive, and 14 (10.9%) patients presented with a CTA spot sign. Inter-rater agreement was very high for all included characteristics between the two readers. Multivariable logistic regression analysis identified the presence of black hole sign (odds ratio 10.59; The distribution and prognostic value of several NCCT markers and CTA spot sign in ICH patients under ORAC is comparable to those with spontaneous ICH, even though these parameters are partly based on coagulant status. These findings suggest that a similar approach can be used for further research regarding outcome prediction in ICH patients under ORAC and those with spontaneous ICH.

Identifiants

pubmed: 32290209
pii: jcm9041077
doi: 10.3390/jcm9041077
pmc: PMC7230516
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet. 2009 May 9;373(9675):1632-44
pubmed: 19427958
Acta Neurochir (Wien). 2018 Aug;160(8):1663-1670
pubmed: 29943191
Stroke. 1998 Jun;29(6):1160-6
pubmed: 9626289
J Stroke. 2017 Sep;19(3):333-339
pubmed: 29037015
Neurology. 2017 Aug 8;89(6):548-554
pubmed: 28701501
Health Technol Assess. 2019 Jul;23(35):1-48
pubmed: 31322116
Stroke. 2010 Feb;41(2):402-9
pubmed: 20044536
Stroke. 2017 Apr;48(4):1120-1125
pubmed: 28289239
Lancet Neurol. 2012 Apr;11(4):307-14
pubmed: 22405630
Ann Neurol. 2019 Oct;86(4):480-492
pubmed: 31364773
Stroke. 2018 Oct;49(10):2317-2322
pubmed: 30355120
Neurology. 2006 Apr 25;66(8):1175-81
pubmed: 16636233
Neuroepidemiology. 2015;45(3):161-76
pubmed: 26505981
Stroke. 2016 May;47(5):1227-32
pubmed: 27073236
Stroke. 1993 Jul;24(7):987-93
pubmed: 8322400
Stroke. 2017 Jan;48(1):131-135
pubmed: 27879447
Stroke. 2018 May;49(5):1163-1169
pubmed: 29669875
Int J Stroke. 2014 Oct;9(7):840-55
pubmed: 25156220
N Engl J Med. 2016 Sep 15;375(11):1033-43
pubmed: 27276234
Neurocrit Care. 2015 Oct;23(2):179-87
pubmed: 25963292

Auteurs

Sebastian Zimmer (S)

Institute of Clinical Radiology, Westfaelische Wilhelms-University of Münster and University Hospital of Muenster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149 Muenster, Germany.

Jörn Meier (J)

Institute of Clinical Radiology, Westfaelische Wilhelms-University of Münster and University Hospital of Muenster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149 Muenster, Germany.
Department of Medicine B, University Hospital Münster, 48149 Münster, Germany.

Jens Minnerup (J)

Department of Neurology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149 Muenster, Germany.

Moritz Wildgruber (M)

Institute of Clinical Radiology, Westfaelische Wilhelms-University of Münster and University Hospital of Muenster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149 Muenster, Germany.

Gabriel Broocks (G)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

Jawed Nawabi (J)

Department of Radiology, Charité University Hospital, Charitéplatz 1, 10117 Berlin, Germany.

Andrea Morotti (A)

Neurology Unit, ASST Valcamonica, 25040 Esine (BS), Italy.

Andre Kemmling (A)

Department of Neuroradiology, Westpfalz-Klinikum, 67655 Kaiserslautern, Germany.

Marios Psychogios (M)

Department of Neuroradiology, Clinic of Radiology & Nuclear Medicine, University Hospital Basel, 4031 Basel, Switzerland.

Uta Hanning (U)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

Peter B Sporns (PB)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.
Department of Neuroradiology, Clinic of Radiology & Nuclear Medicine, University Hospital Basel, 4031 Basel, Switzerland.

Classifications MeSH